Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?

Stephanie L. Harrison; Martín O’Flaherty; Professor Gregory Lip

doi:10.1093/qjmed/hcz310

Related publications

Article2019

Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1

Gaurav Panchal, Maria Mahmood, Professor Gregory Lip

Article2019

Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2

Gaurav Panchal, Maria Mahmood, Professor Gregory Lip

Article2009

Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation

Renate B. Schnabel, Martin G. Larson, Jennifer F. Yamamoto, Sekar Kathiresan, Jian Rong, Daniel Levy, John F. Keaney, Thomas J. Wang, Ramachandran S. Vasan, Emelia Benjamin

Article2018

Nonsteroidal anti‐inflammatory drug use and breast cancer risk in a European prospective cohort study

Manon Cairat, A. Fournier, Neil Murphy, Carine Biessy, Augustin Scalbert, Sabina Rinaldi, Anne Tjønneland, Anja Olsen, Kim Overvad, Patrick Arveux, Marie‐Christine Boutron‐Ruault, Claire Cadeau, Renée T. Fortner, Rudolf Kaaks, Heiner Boeing, Krasimira Aleksandrova, Petra H. Peeters, Carla H. van Gils, Nicholas J. Wareham, Kay‐Tee Khaw, Dagfinn Aune, Elio Riboli, Marc J. Gunter,

Article2023

Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysis

Yi Zheng, Nan Zhang, Gary Tse, Guangping Li, Professor Gregory Lip, Tong Liu